Microsaic Systems plc AGM Statement (0149N)
May 04 2018 - 2:00AM
UK Regulatory
TIDMMSYS
RNS Number : 0149N
Microsaic Systems plc
04 May 2018
4 May 2018
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
AGM Statement
Microsaic Systems plc (AIM: MSYS) will hold its AGM today, at 11
am, at the offices of Nplus1 Singer Advisory LLP, One Bartholomew
Lane, London, EC2N 2AX, where the Company's Chairman, Peter Grant,
will make the following statement:
"The Board is pleased to report encouraging progress with the
Company's commercial development since the announcement of the 2017
results on 5 March 2018.
The collaboration with one of the foremost players in the global
market for scientific instrumentation is progressing in line with
the Board's expectations in the technical integration phase of a
bioprocessing application.
As previously announced, two new OEM agreements have been signed
in the Company's traditional small molecule markets.
On 28 March, the Company announced an agreement with Unimicro
Technologies Inc. ("Unimicro"), for the integration of its compact
4500 MiD(R) mass spectrometry ("MS") detector with Unimicro's
Capillary Electrophoresis platform. Once integrated, the combined
product will be sold by Unimicro in China via its extensive
distribution network.
In April, Microsaic signed an agreement with Knauer
Wissenschaftliche Geräte GmbH ("Knauer"), for the integration of
Microsaic's compact 4500 MiD(R)MS technology into Knauer's liquid
chromatography platform, and for the combined product to be sold
direct by Knauer in Germany and globally via its extensive
distribution network.
Orders received in the year to date are from a wider customer
base than last year and in total cover the same number of
instruments as delivered for the whole of 2017. The Board remains
confident in the longer-term prospects for the business."
Enquiries:
Microsaic Systems plc
Glenn Tracey, CEO
Bevan Metcalf, FD +44 (0) 1483 751577
N+1 Singer (Nominated Adviser &
Broker)
Shaun Dobson
Liz Yong +44 (0)20 7496 3000
IFC Advisory Ltd (Financial PR)
Graham Herring
Heather Armstrong +44 (0)20 3934 6630
About Microsaic Systems
Microsaic Systems plc (AIM: MSYS) is a high technology company
developing chip-based, bench-top and point-of-analysis mass
spectrometry ("MS") instruments that are designed to improve the
efficiency of pharmaceutical R&D and manufacturing. The Company
is working with established global life science companies to
co-develop new solutions to improve productivity in the development
of small molecule and novel biologic (peptides, antibodies)
medicines. MS is a powerful method of analysis to enable earlier
decision making relating to product identification, purity and
bioactivity, and is the analytical technique of choice for
biochemists across many industry sectors.
Microsaic's core product, the 4500 MiD(R), is a robust and
compact MS system, retaining the functionality of larger
conventional MS systems, is easier to use by non-specialists,
consumes less energy and has lower running costs. For more
information, please go to www.microsaic.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMAJMLTMBMMMBP
(END) Dow Jones Newswires
May 04, 2018 02:00 ET (06:00 GMT)
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From Apr 2024 to May 2024
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From May 2023 to May 2024